Resumo

RIVERA DIAZ, Roberto Carlo; ARCILA LOTERO, Mario Andrés  e  CAMPUZANO ESCOBAR, Daniel. Intrathecal baclofen for the treatment of spasticity. Case report with thematic review. Rev. colomb. anestesiol. [online]. 2013, vol.41, n.3, pp.229-235. ISSN 0120-3347.  https://doi.org/10.1016/j.rca.2013.03.004.

Introduction: Spasticity is triggered by a central nervous system disorder and may be local or generalized. The severity of symptoms, including functional limitation, deformity, pain, sleep disorders, depression and multiple disabilities, depends on the areas involved. The treatment of the disease is based on physical therapy and complemented with posture correcting devices, a few surgical interventions and drug therapy. Baclofen is a useful drug for this pathology and is usually administered orally; however, due to its low bioavailability or poor tolerance some patients require intrathecal administration. Objective: The purpose of this article is to present a literature review based on a case report of a patient with a diagnosis of spastic tetraparesis, receiving intrathecal baclofen treatment through an implantable intrathecal therapy pump (ITP). Methods and materials: A database search was conducted in EBSCO, MEDLINE and OVID that included systematic review articles, clinical trials, narrative reviews and case series between 1995 and 2012, for a non-systematic narrative review and a case report. Results: 35 articles were considered in total for an update on the topic suggested. Conclusions: Baclofen use through an implanted ITP is an effective and safe option for treating patients with severe spasticity refractory to conventional oral therapy.

Palavras-chave : Baclofen; Pain; Central Nervous; System Paresis; Gamma-Aminobutyric Acid.

        · resumo em Espanhol     · texto em Espanhol | Inglês     · Inglês ( pdf ) | Espanhol ( pdf )